Atlas Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Atlas Capital Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$406K	Buy	4,769 +11	+0.2%	+$980	0.05%	290
2025 Q4	$376K	Buy	+4,758	New	+$373K	0.04%	313
2025 Q2	$4.36K	Hold	48	–	–	﹤0.01%	821
2025 Q1	$4.5K	Hold	48	–	–	﹤0.01%	855
2024 Q4	$4.36K	Hold	48	–	–	﹤0.01%	832
2024 Q3	$4.98K	Hold	48	–	–	﹤0.01%	776
2024 Q2	$4.66K	Hold	48	–	–	﹤0.01%	785
2024 Q1	$4.32K	Hold	48	–	–	﹤0.01%	772
2023 Q4	$3.83K	Hold	48	–	–	﹤0.01%	800
2023 Q3	$3.41K	Hold	48	–	–	﹤0.01%	780
2023 Q2	$3.7K	Sell	48 -43	-47%	-$3.33K	﹤0.01%	801
2023 Q1	$6.84K	Hold	91	–	–	﹤0.01%	771
2022 Q4	$7.17K	Hold	91	–	–	﹤0.01%	761
2022 Q3	$6.39K	Hold	91	–	–	﹤0.01%	754
2022 Q2	$7.29K	Buy	91 +43	+90%	+$3.36K	﹤0.01%	790
2022 Q1	$3.64K	Hold	48	–	–	﹤0.01%	820
2021 Q4	$4.1K	Hold	48	–	–	﹤0.01%	810
2021 Q3	$3.63K	Hold	48	–	–	﹤0.01%	831
2021 Q2	$3.9K	Buy	+48	New	+$3.92K	﹤0.01%	840

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Atlas Capital Advisors's CL Position: Q1 2026 in Review

Atlas Capital Advisors increased its Colgate-Palmolive (CL) stake by 0.23% in Q1 2026, buying an estimated $980 and bringing the position to 4,769 shares worth $406K. The position accounts for 0.05% of the portfolio, ranked #290.

Atlas Capital Advisors first reported a position in CL in Q2 2021 and has held it in 19 quarters since. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Atlas Capital Advisors held 4,769 shares of Colgate-Palmolive worth $406K as of Q1 2026.
Atlas Capital Advisors bought 11 Colgate-Palmolive shares in Q1 2026, an estimated $980.
Colgate-Palmolive made up 0.05% of Atlas Capital Advisors's portfolio in Q1 2026, its #290 holding.
Atlas Capital Advisors first reported a position in Colgate-Palmolive in Q2 2021 and has held it in 19 quarters since.
1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Atlas Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.